Jeffrey L. Wade
2008
In 2008, Jeffrey L. Wade earned a total compensation of $648.1K as Executive Vice President, Corporate Development and Chief Financial Officer at Lexicon Pharmaceuticals, a 20% decrease compared to previous year.
Compensation breakdown
| Option Awards | $303,540 |
|---|---|
| Salary | $338,333 |
| Other | $6,235 |
| Total | $648,108 |
Wade received $338.3K in salary, accounting for 52% of the total pay in 2008.
Wade also received $303.5K in option awards and $6.2K in other compensation.
Rankings
In 2008, Jeffrey L. Wade's compensation ranked 5,700th out of 9,135 executives tracked by ExecPay. In other words, Wade earned more than 37.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,700 out of 9,135 | 38th |
Division Manufacturing | 2,084 out of 3,436 | 39th |
Major group Chemicals And Allied Products | 439 out of 815 | 46th |
Industry group Drugs | 283 out of 597 | 53rd |
Industry Pharmaceutical Preparations | 209 out of 408 | 49th |
Source: SEC filing on March 18, 2011.
Wade's colleagues
We found five more compensation records of executives who worked with Jeffrey L. Wade at Lexicon Pharmaceuticals in 2008.
2008
Arthur Sands
Lexicon Pharmaceuticals
Chief Executive Officer
2008
Brian Zambrowicz
Lexicon Pharmaceuticals
Chief Scientific Officer
2008
Julia Gregory
Lexicon Pharmaceuticals
Chief Financial Officer
2008
Alan Main
Lexicon Pharmaceuticals
Executive Vice President of Pharmaceutical Research
2008
James Tessmer
Lexicon Pharmaceuticals
Vice President, Finance and Accounting
News
Lexicon Pharmaceuticals CEO Lonnel Coats' 2023 pay slips 1% to $4.1M
March 26, 2024
Lexicon Pharmaceuticals CEO Lonnel Coats' 2021 pay rises 2% to $3.9M
April 8, 2022
Lexicon Pharmaceuticals CEO Lonnel Coats' 2020 pay stays at $3.9M
March 19, 2021
Lexicon Pharmaceuticals CEO Lonnel Coats' 2019 pay jumps 24% to $3.9M
March 13, 2020
Lexicon Pharmaceuticals CEO Lonnel Coats' 2018 pay jumps 41% to $3.1M
March 14, 2019